Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy

Wongpaitoon, Virasak; Mills, Peter R.; Russell, Robin; Patrick, R. S.

doi:10.1136/pgmj.57.666.244

Cited by 28 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Whereas the prototype compounds such as carbutamide were associated with significant liver toxicity, subsequent generations of sulfonylureas such as chlorpropamide, glibenclamide, tolbutamide, and tolazamide have been occasionally implicated in liver toxicity (Table 3). [94][95][96][97][98][99][100] Recent additions include gliclazide 101,102 and glimepiride. 103 Fever, rash, and eosinophilia may be present, consistent with a hypersensitivity-related reaction.…”

Section: Sulfonylureasmentioning

confidence: 99%

Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs

Chitturi¹,

George²

2002

Semin Liver Dis

194

106

View full text Add to dashboard Cite

Hepatotoxic adverse drug reactions have contributed to the decline of many promising therapies, even among mainstream medication classes (bromfenac and troglitazone are recent examples). The spectrum of nonsteroidal anti-inflammatory drug-related liver toxicity continues to expand, with reports in children, interactive toxicity in persons with hepatitis C, and recognition of the toxicity of both the preferential and selective cyclooxygenase-2 inhibitors. Of the antihypertensive agents, methyldopa is now rarely prescribed and adverse effects are reported infrequently, whereas cases of liver injury associated with the angiotensin receptor and converting enzyme inhibitors are increasingly reported. Of the antidiabetic agents, acarbose, gliclazide, metformin, and human insulin have been implicated in causing liver injury. To date, the newer thiazolidinediones do not appear to share the hepatotoxic potential of troglitazone, although a few reports of acute hepatitis have accrued. Although liver injury has been associated with the "statins," the frequency of such toxicity is lower than that of the background population and the value of biochemical monitoring remains unproved. Newer concepts in anticonvulsant hepatotoxicity have been the recognition of the reactive metabolite syndrome, delineation of the risk factors for valproic acid toxicity, the potential role of carnitine in preventing valproic acid hepatotoxicity, and the toxicity of second-line antiepileptic drugs. Liver injury associated with newer psychotropic agents, particularly the selective serotonin reuptake inhibitors, is also discussed. The focus of the review is the hepatotoxicity of commonly used drugs with particular reference to recent and novel reports of toxicity. Well-known causes of liver injury such as chlorpromazine, phenytoin, and methyldopa are not discussed.

show abstract

Section: Sulfonylureasmentioning

confidence: 99%

Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs

Chitturi¹,

George²

2002

Semin Liver Dis

194

106

View full text Add to dashboard Cite

show abstract

“…En este sentido, la hiperglicemia puede ser tratada inicialmente con fármacos hipoglucemiantes como son metformina (Knowler et al, 2002) y glibenclamida (O´Sullivan & Cashman, 1970) entre otros (Zarate y Tene, 1999). Sin embargo, algunos de estos medicamentos tienden a producir algunos efectos secundarios (Wongpaitoon et al, 1981;Salper et al, 2003) y además son relativamente costosos para países en vías de desarrollo. Por lo tanto, se requiere de alternativas farmacológicas que ayuden al tratamiento de la diabetes, en este contexto, desde hace varias décadas se ha usado la medicina tradicional como una alternativa, que involucra el manejo de plantas con finalidades terapéuticas en los países que se encuentran en vías de desarrollo (Mahair & Gulliford, 1997;Funke et al, 2006).…”

Section: Introductionunclassified

Efectos inducidos por Ruta graveolens L., Cnidoscolus chayamansa McVaugh y Citrus aurantium L. sobre los niveles de glucosa, colesterol y triacilglicéridos en un modelo de rata diabética

Figueroa‐Valverde¹,

Díaz-Cedillo²,

Camacho‐Luis³

et al. 2009

Rev. bras. farmacogn.

View full text Add to dashboard Cite

RESUMO: "Efeitos induzidos por Ruta graveolens L., Rutaceae, Cnidoscolus chayamansa McVaugh, Euphorbiaceae, e Citrus aurantium L., Rutaceae, nos níveis de glucose, colesterol e triacilglicerídeos num modelo do rato diabético". Diversas plantas com propriedades hipoglicêmicas foram usadas na medicina popular e em sistemas tradicionais de curas em torno do mundo. A finalidade deste trabalho foi avaliar os efeitos induzidos por Ruta graveolens L, Rutaceae, Cnidoscolus chayamansa McVaugh, Euphorbiaceae, e Citrus aurantium L., Rutaceae, em modelo do rato diabético onde níveis da glucose foram determinados a cada 24 h em um mês antes da administração gástrica do extrato das plantas. Colesterol e triacilglicerídeos foram avaliados usando técnicas enzimáticas. Os resultados mostraram que a administração de Cnidoscolus chayamansa a dose de 0,5 a 1,5 g/kg induz um aumento hipoglicêmico (< 200 mg/dL). Outros dados indicam que Cnidoscolus chayamansa exerce variações nos níveis de triacilglicerídeos (80-90 mg/dL) e colesterol (88-96 mg/dL). A administração de Citrus aurantium nas mesmas doses não foi suficiente para diminuir os níveis de glucose (> 200 mg/dL). Outros resultados, mostraram que Citrus aurantium exerce mudanças na concentração de triacilglicerídeos (158-172 mg/dL) e colesterol (120-128 mg/dL). Finalmente, a administração de Ruta graveolens na dose de 0.5 g/ kg induziu um efeito hipoglicêmico (< 200 mg/dL). Ruta graveolens, na dose de 0.5 a 1.5 g/kg, induziu variações nos níveis de triacilglicerídeos (110-120 mg/dL) e colesterol (116-124 mg/dL). Em conclusão, a administração de Cnidoscolus chayamansa exerce efeitos hipoglicêmicos numa maneira dose dependente em comparação com Ruta graveolens e Citrus aurantium. As plantas avaliadas induzem mudanças nos níveis de lipídeos dependente da dose.Unitermos: Diabetes, Cnidoscolus chayamansa, Ruta graveolens, Citrus aurantium, Wistar.ABSTRACT: "Induced effects by Ruta graveolens L., Rutaceae, Cnidoscolus chayamansa McVaugh, Euphorbiaceae, and Citrus aurantium L., Rutaceae, on glucose, cholesterol and triacylglycerides levels in a diabetic rat model". Several plants with hypoglycemic properties have been used in folk medicine and traditional healing systems around the world. The purpose of this work was to evaluate the effects of Ruta graveolens L., Rutaceae, Cnidoscolus chayamansa McVaugh, Euphorbiaceae, and Citrus aurantium L., Rutaceae, in a diabetic rat model to which the glucose levels were quantified every 24 hours by one month before of gastric administration of plants extract. Additionally, the cholesterol and triacylglycerides were evaluated using standard enzymatic techniques. The results showed that increases in the dose (0.5 to 1.5 g/kg) of Cnidoscolus chayamansa induce a high hypoglycemic effect (< 200 mg/dL). Another data indicate that Cnidoscolus chayamansa exerts variations in triacylglycerides (80-90 mg/dL) and cholesterol (88-96 mg/dL). Nevertheless, the administration of Citrus aurantium in the same doses was not sufficient for diminish the glucose leve...

show abstract

“…He had been on Glyburide for three years [11]. Wongpaitoon et al described a case of intrahepatic cholestasis and cutaneous bullae after five months of using Glyburide [12]. In these case reports, liver enzymes normalized between one to two weeks after the medication was discontinued.…”

Section: Discussionmentioning

confidence: 99%

Untitled

2018

DMD

View full text Add to dashboard Cite

Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy

Cited by 28 publications

References 17 publications

Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs

Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs

Efectos inducidos por Ruta graveolens L., Cnidoscolus chayamansa McVaugh y Citrus aurantium L. sobre los niveles de glucosa, colesterol y triacilglicéridos en un modelo de rata diabética

Untitled

Contact Info

Product

Resources

About